Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...

70.8% of those who were aware of their hypertension status and met criteria for meds had uncontrolled hypertension ...

Use of a multidisciplinary care management pathway may improve pregnancy outcomes among women with SLE who previously had adverse obstetric outcomes.

Weight reduction at 1 year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

In a UK Biobank study, CMM risk increased with the number of chronic pain sites, and having more pain sites increased risk of T2D, IHD, and stroke.

In patients with kidney cancer undergoing surgery, the risk for kidney failure (ESRD) appears no lower with partial kidney removal (nephrectomy).

(HealthDay News) — The overall second primary malignancy (SPM) point estimate was 5.8% for patients receiving chimeric antigen receptor (CAR) T-cell therapy, according to a study published online in ...

Medicare has a proposed a 2.8% reduction in its Physician Fee Schedule conversion factors that could put a financial squeeze on independent urology practices.

Interleukin-6 levels were associated with an increased risk for obesity-related cancer among individuals with newly diagnosed type 2 diabetes.

Tirzepatide vs GLP-1 agonists demonstrated superior cardiorenal benefits among patients with type 2 diabetes. Treatment with tirzepatide, compared with glucagon-like peptide 1 (GLP-1) receptor ...

Once-weekly efsitora noninferior to once-daily degludec for decrease in mean glycated hemoglobin level.

Significant associations were found between certain autoantibodies and neuropsychiatric manifestations of SLE.